Nephrology

2020

1. Analysis of Factors Influencing the Prognostic Significance of Hyponatremia in Peritoneal Dialysis Patients

   American Journal of Nephrology, Vol. 51, Núm. 1, pp. 54-64

2. Angiotensin II suppression in SARS-CoV-2 infection: a therapeutic approach

   Nefrologia, Vol. 40, Núm. 3, pp. 213-216

3. Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease

   Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024

4. Association of single nucleotide polymorphisms with renal cell carcinoma in Algerian population

   African Journal of Urology, Vol. 26, Núm. 1

5. Bedtime hypertension chronotherapy best reduces cardiovascular disease risk as corroborated by the Hygia Chronotherapy Trial. Rebuttal to European Society of Hypertension officials.

   Chronobiology International, pp. 1-10

6. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial

   European heart journal, Vol. 41, Núm. 48, pp. 4565-4576

7. COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration

   Nephrology Dialysis Transplantation, Vol. 35, Núm. 11, pp. 1973-1983

8. Complement genes contribute sex-biased vulnerability in diverse disorders

   Nature, Vol. 582, Núm. 7813, pp. 577-581

9. CystAnalyser: A new software tool for the automatic detection and quantification of cysts in polycystic kidney and liver disease, and other cystic disorders

   PLoS Computational Biology, Vol. 16, Núm. 10

10. De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia

    Nature Neuroscience, Vol. 23, Núm. 2, pp. 179-184

11. Documento de consenso para la formación en ecografía en la especialidad de Nefrología

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 40, Núm. 6, pp. 623-633

12. Does Timing of Antihypertensive Medication Dosing Matter?

    Current Cardiology Reports, Vol. 22, Núm. 10

13. Effectiveness and safety of the conversion to MeltDose® extended-release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study

    Clinical Transplantation, Vol. 34, Núm. 1

14. First-Days Reduction of Plasma and Skin Advanced Glycation End Products is Related to Outcome in Septic Patients

    Shock, Vol. 53, Núm. 4, pp. 400-406

15. New perspectives on the definition, diagnosis, and treatment of true arterial hypertension

    Expert Opinion on Pharmacotherapy, Vol. 21, Núm. 10, pp. 1167-1178

16. Prevalence of Immunological Defects in a Cohort of 97 Rubinstein–Taybi Syndrome Patients

    Journal of Clinical Immunology, Vol. 40, Núm. 6, pp. 851-860

17. Randomized clinical trial to determine the effectiveness of CO-oximetry and anti-smoking brief advice in a cohort of kidney transplant patients who smoke

    International Journal of Medical Sciences, Vol. 17, Núm. 17, pp. 2673-2684

18. Ribavirin as a first treatment approach for hepatitis e virus infection in transplant recipient patients

    Microorganisms, Vol. 8, Núm. 1

19. Situación de la infección por SARS-CoV-2 en pacientes en tratamiento renal sustitutivo. Informe del Registro COVID-19 de la Sociedad Española de Nefrología (SEN)

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 40, Núm. 3, pp. 272-278